Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study (vol 27, pg 329, 2009)

被引：0
|
作者：
Pizzi, L. T.
Talati, A.
Gemmen, E.
Dahl, N., V
Bunz, T. J.
Sand, P. K.
机构：
[1] Jefferson School of Population Health,Doris N. Grandon Center for Health Economics and Outcomes Research
[2] Jefferson School of Population Health,Evanston Continence Center
[3] Quintiles,undefined
[4] Watson Laboratories,undefined
[5] Inc.,undefined
[6] Northwestern University,undefined
[7] Feinberg School of Medicine,undefined
来源：
PHARMACOECONOMICS | 2012年 / 30卷 / 06期
关键词：
D O I：
10.2165/11633660-000000000-00000
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [21] TOLERABILITY OF SOLIFENACIN IN COMPARISON WITH OXYBUTYNIN IMMEDIATE RELEASE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS OF THE VECTOR STUDY
    Herschorn, Sender
    Pommerville, Peter
    Stothers, Lynn
    Egerdie, Blair
    Gajewski, Jerzy
    Carlson, Kevin
    Radomski, Sidney
    Drutz, Harold
    Schulz, Jane
    Barkin, Jack
    Hirshberg, Eric
    Corcos, Jacques
    JOURNAL OF UROLOGY, 2009, 181 (04): : 557 - 557
  • [22] Impact of overactive bladder on quality of life in older patients: Interim results of the matrix study.
    Dmochowski, RR
    Reaves, LA
    Hale, DS
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S160 - S161
  • [23] Comparison of depression symptoms in patients with OAB before and after treatment with transdermal oxybutynin: Results from the matrix study
    Cafiero, MR
    Maloney-Monaghan, C
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2006, 33 (03) : S6 - S6
  • [24] IMPACT OF MIRABEGRON TREATMENT AND SYMPTOM SEVERITY ON WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH OVERACTIVE BLADDER
    De, G.
    Yang, H.
    Runken, M. C.
    Yan, Y.
    Kelkar, S.
    Bui, C. N.
    Xie, J.
    Wu, E. Q.
    VALUE IN HEALTH, 2013, 16 (03) : A183 - A184
  • [25] Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions
    Antoni Sicras-Mainar
    Ruth Navarro-Artieda
    Amador Ruiz-Torrejón
    Marc Sáez-Zafra
    Gabriel Coll-de Tuero
    Clinical Drug Investigation, 2015, 35 : 795 - 805
  • [26] Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions
    Sicras-Mainar, Antoni
    Navarro-Artieda, Ruth
    Ruiz-Torrejon, Amador
    Saez-Zafra, Marc
    Coll-de Tuero, Gabriel
    CLINICAL DRUG INVESTIGATION, 2015, 35 (12) : 795 - 805
  • [27] Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER
    Zinner, Norman
    Noe, Les
    Rasouliyan, Lawrence
    Marshall, Thomas
    Seifeldin, Raafat
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (06) : 1583 - 1591
  • [28] The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS
    Coyne, Karin S.
    Sexton, Chris C.
    Kopp, Zoe S.
    Ebel-Bitoun, Caty
    Milsom, Ian
    Chapple, Chris
    BJU INTERNATIONAL, 2011, 108 (09) : 1459 - 1471
  • [29] IMPACT OF SOLIFENACIN ON SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, TREATMENT SATISFACTION, AND SYMPTOMS IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM VIBRANT
    Mitcheson, H. D.
    Roy, J. B.
    Gilmet, G.
    Marshall, T. S.
    Shannon, J. B.
    VALUE IN HEALTH, 2009, 12 (03) : A201 - A201
  • [30] TOLERABILITY OF SOLIFENACIN IN COMPARISON WITH OXYBUTYNIN IMMEDIATE RELEASE IN ELDERLY SUBJECTS WITH OVERACTIVE BLADDER: SUBANALYSIS OF RESULTS FROM THE VECTOR STUDY
    Herschorn, S.
    Pommerville, P.
    Stothers, L.
    Egerdie, B.
    Gajewski, J.
    Carlson, K.
    Radomski, S.
    Drutz, H.
    Schulz, J.
    Barkin, J.
    Hirshberg, E.
    Corcos, J.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 : S184 - S185
12345